There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.
Monica Chmielewski and Alexandra Maulden
Advertisement
Articles by Monica Chmielewski and Alexandra Maulden
Advertisement
Latest Updated Articles
An Overview of FDA Diversity-Related Documents for Clinical TrialsPublished: May 30th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
dashClinical: Real-Time Participant Payments
4
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
